176 related articles for article (PubMed ID: 35083530)
1. The effect of gender-affirming hormone treatment on serum creatinine in transgender and gender-diverse youth: implications for estimating GFR.
Millington K; Barrera E; Daga A; Mann N; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
Pediatr Nephrol; 2022 Sep; 37(9):2141-2150. PubMed ID: 35083530
[TBL] [Abstract][Full Text] [Related]
2. A Retrospective Analysis of Creatinine-Based Kidney Function With and Without Sex Assigned at Birth Among Transgender Adults.
Fadich SK; Kalayjian A; Greene DN; Cirrincione LR
Ann Pharmacother; 2022 Jul; 56(7):791-799. PubMed ID: 34668423
[TBL] [Abstract][Full Text] [Related]
3. Cystatin C-Based eGFR Changes during Gender-Affirming Hormone Therapy in Transgender Individuals.
van Eeghen SA; Wiepjes CM; T'Sjoen G; Nokoff NJ; den Heijer M; Bjornstad P; van Raalte DH
Clin J Am Soc Nephrol; 2023 Dec; 18(12):1545-1554. PubMed ID: 37678248
[TBL] [Abstract][Full Text] [Related]
4. Physiological and Metabolic Characteristics of a Cohort of Transgender and Gender-Diverse Youth in the United States.
Millington K; Schulmeister C; Finlayson C; Grabert R; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
J Adolesc Health; 2020 Sep; 67(3):376-383. PubMed ID: 32417098
[TBL] [Abstract][Full Text] [Related]
5. Bone Mineral Density in Transgender Adolescents Treated With Puberty Suppression and Subsequent Gender-Affirming Hormones.
van der Loos MATC; Vlot MC; Klink DT; Hannema SE; den Heijer M; Wiepjes CM
JAMA Pediatr; 2023 Dec; 177(12):1332-1341. PubMed ID: 37902760
[TBL] [Abstract][Full Text] [Related]
6. Psychosocial Functioning in Transgender Youth after 2 Years of Hormones.
Chen D; Berona J; Chan YM; Ehrensaft D; Garofalo R; Hidalgo MA; Rosenthal SM; Tishelman AC; Olson-Kennedy J
N Engl J Med; 2023 Jan; 388(3):240-250. PubMed ID: 36652355
[TBL] [Abstract][Full Text] [Related]
7. Psychosocial Characteristics of Transgender Youth Seeking Gender-Affirming Medical Treatment: Baseline Findings From the Trans Youth Care Study.
Chen D; Abrams M; Clark L; Ehrensaft D; Tishelman AC; Chan YM; Garofalo R; Olson-Kennedy J; Rosenthal SM; Hidalgo MA
J Adolesc Health; 2021 Jun; 68(6):1104-1111. PubMed ID: 32839079
[TBL] [Abstract][Full Text] [Related]
8. Development of Hip Bone Geometry During Gender-Affirming Hormone Therapy in Transgender Adolescents Resembles That of the Experienced Gender When Pubertal Suspension Is Started in Early Puberty.
van der Loos MA; Hellinga I; Vlot MC; Klink DT; den Heijer M; Wiepjes CM
J Bone Miner Res; 2021 May; 36(5):931-941. PubMed ID: 33507568
[TBL] [Abstract][Full Text] [Related]
9. SERUM HORMONE CONCENTRATIONS IN TRANSGENDER INDIVIDUALS RECEIVING GENDER-AFFIRMING HORMONE THERAPY: A LONGITUDINAL RETROSPECTIVE COHORT STUDY.
Chantrapanichkul P; Stevenson MO; Suppakitjanusant P; Goodman M; Tangpricha V
Endocr Pract; 2021 Jan; 27(1):27-33. PubMed ID: 33471729
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Gender-Affirming Hormone Therapy on Measures of Kidney Function: A Systematic Review and Meta-Analysis.
Krupka E; Curtis S; Ferguson T; Whitlock R; Askin N; Millar AC; Dahl M; Fung R; Ahmed SB; Tangri N; Walsh M; Collister D
Clin J Am Soc Nephrol; 2022 Sep; 17(9):1305-1315. PubMed ID: 35973728
[TBL] [Abstract][Full Text] [Related]
11. Laboratory Changes During Gender-Affirming Hormone Therapy in Transgender Adolescents.
Millington K; Lee JY; Olson-Kennedy J; Garofalo R; Rosenthal SM; Chan YM
Pediatrics; 2024 May; 153(5):. PubMed ID: 38567424
[TBL] [Abstract][Full Text] [Related]
12. Bone Health in the Transgender and Gender Diverse Youth Population.
Lee JY
Curr Osteoporos Rep; 2023 Aug; 21(4):459-471. PubMed ID: 37395890
[TBL] [Abstract][Full Text] [Related]
13. Association of Gonadotropin-Releasing Hormone Analogue Use With Subsequent Use of Gender-Affirming Hormones Among Transgender Adolescents.
Nos AL; Klein DA; Adirim TA; Schvey NA; Hisle-Gorman E; Susi A; Roberts CM
JAMA Netw Open; 2022 Nov; 5(11):e2239758. PubMed ID: 36318207
[TBL] [Abstract][Full Text] [Related]
14. A European Network for the Investigation of Gender Incongruence in adolescents.
Boogers LS; Wiepjes CM; Staphorsius AS; Klink DT; Ciancia S; Romani A; Stolk THR; van den Boogaard E; Steensma TD; de Vries ALC; van Trotsenburg ASP; den Heijer M; Fisher AD; Cools M; Hannema SE
J Sex Med; 2024 Mar; 21(4):350-356. PubMed ID: 38427555
[TBL] [Abstract][Full Text] [Related]
15. Providing Care for Transgender Persons With Kidney Disease: A Narrative Review.
Collister D; Saad N; Christie E; Ahmed S
Can J Kidney Health Dis; 2021; 8():2054358120985379. PubMed ID: 33552529
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Gender-Affirming Hormone Therapy on Serum Creatinine in Transgender Individuals.
Maheshwari A; Dines V; Saul D; Nippoldt T; Kattah A; Davidge-Pitts C
Endocr Pract; 2022 Jan; 28(1):52-57. PubMed ID: 34474185
[TBL] [Abstract][Full Text] [Related]
17. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
18. A Holistic Framework for the Evaluation of Kidney Function in a Gender-Diverse Landscape.
Turino Miranda K; Greene DN; Collister D; Krasowski MD; Ahmed SB; Cirrincione LR; Rosas SE; Saad N; Pierre CC
Am J Kidney Dis; 2024 Mar; ():. PubMed ID: 38458377
[TBL] [Abstract][Full Text] [Related]
19. Reference Intervals for Clinical Chemistry Analytes for Transgender Men and Women on Stable Hormone Therapy.
Humble RM; Greene DN; Schmidt RL; Winston McPherson G; Rongitsch J; Imborek KL; Nisly N; Dole NJ; Dane SK; Frerichs J; Krasowski MD
J Appl Lab Med; 2022 Sep; 7(5):1131-1144. PubMed ID: 35584132
[TBL] [Abstract][Full Text] [Related]
20. Lower Serum Estradiol Levels in Assigned Female at Birth Transgender People with Initiation of Testosterone Therapy: Results from the European Network for the Investigation of Gender Incongruence.
Defreyne J; Aers XP; Collet SM; Wiepjes CM; Fisher AD; Schreiner T; Den Heijer M; Kaufman JM; T'Sjoen GGR
LGBT Health; 2020; 7(2):71-81. PubMed ID: 32049583
[No Abstract] [Full Text] [Related]
[Next] [New Search]
